INNOGEN-B 02591Hong Kong Stock Exchange

3.6000.55%( -0.020 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
INNOGEN-B (02591) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
Guangzhou Innogen Pharmaceutical Group Co., Ltd
Market
HKEX Main Board
Listing Date
2025-08-15
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE1000071Q7
Southbound Connect
Shanghai · Shenzhen

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)154.22M84/112
Net Profit (Last FY)-400.30M102/125
ROE (Last FY)-32.41%89/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
WANG QINGHUA Executive Director
姜帆 Executive Director
徐文洁 Executive Director
黄冰 Executive Director
HO KYUNG SHIK Non-Executive Director
衡磊 Non-Executive Director
陶武平 Independent Non-Executive Director
宋瑞霖 Independent Non-Executive Director
陈向荣 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-08-14.

About this page

This page shows INNOGEN-B (02591) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.